Baxter International reported $2.98B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 154.45M 850K Sep/2026
Baxter International USD 2.98B 20M Sep/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Boston Scientific USD 5.14B 300M Sep/2026
Cooper Companies USD 1.07B 15.3M Jun/2026
Dexcom USD 1.34B 30M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Fresenius EUR 5.88B 70M Sep/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Halozyme Therapeutics USD 492.97M 11.97M Sep/2026
ICU Medical USD 556.22M 4.54M Sep/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 842M 40.3M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
J&J USD 25.4B 89M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Merit Medical Systems USD 416.24M 2.56M Sep/2026
Quest Diagnostics USD 3.1B 57M Sep/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
Stryker USD 6.5B 100M Sep/2026
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Terumo JPY 312.69B 881M Sep/2026
Zimmer Biomet Holdings USD 2.06B 120M Sep/2026